Send to a Friend Font Size: Increase Decrease

MIST and ATR Related Headlines

Dec 17, 2025 05:00PM Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Dec 17, 2025 05:00PM Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

MIST and ATR Related Press Releases

Dec 17, 2025 05:00PM Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

MIST and ATR Related SEC Filings